Quest Diagnostics' H1N1 Flu PCR Test Gets FDA Clearance
May 25, 2010
Quest Diagnostics' H1N1 Flu PCR Test Gets FDA Clearance
Simplexa, manufactured by Quest's Focus Diagnostics business, is the first test to be cleared by the FDA to aid in detecting and differentiating influenza A and 2008 H1N1 influenza viral RNA.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quest's Goal of Shifting Some MDx Testing to Hospital Labs Gains Momentum
April 28, 2011 / The Sample - Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV Test on 3M Instrument
August 26, 2010 / PCR Insider - PCR Probe Licensing Pact with Focus Diagnostics Portends 'Busy Year' for Evogen
March 14, 2013 / PCR Insider - Dx Focus: Focus Diagnostics' Simplexa Flu A/B & RSV Test
October 11, 2012 / PCR Insider - Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil
December 8, 2011 / PCR Insider